Chris Freeman - Nov 8, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Stock symbol
GH
Transactions as of
Nov 8, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 06:11 PM
Previous filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Award $0 +45.2K $0.00 45.2K Nov 8, 2024 Common Stock 45.2K $28.61 Direct F1
transaction GH Restricted Stock Units Award $0 +30.2K $0.00 30.2K Nov 8, 2024 Common Stock 30.2K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F2 This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.